Product Overview

As the latest generation of Tianlong Technology products, the GeneRotex 48 rotary nucleic acid extractor is specifically designed for nucleic acid extraction of large-volume samples. Designed according to the principles of magnetic bead method and rotary nucleic acid extraction technology, GeneRotex 948 can achieve the rapid and efficient preparation of nucleic acids from large-volume samples. With special large-volume sample nucleic acid extraction reagents, it can process swabs, whole blood, serum, plasma, tissue fluid, urine and other sample types. It is widely used in the fields of disease prevention and control, animal quarantine, clinical diagnosis, entry-exit inspection and quarantine, food and drug administration, teaching and scientific research.

Features:

Sample processing volume of up to 1000 μL, suitable for large-volume samples or sample pooling. Efficient extraction, with automated nucleic acid extraction of 48 samples completed within 20min. The use of rotary nucleic acid extraction, combined with air filtration and UV light disinfection measures, can greatly reduce the risk of contamination, and provide a more efficient and silent extraction process. Various operation modes: touch-screen operation, or remote operation in an app via a scanner. Motor-driven automatic opening and closing of the experiment cabinet.

Since its establishment in 1997, Tianlong has been committed to the research and development, production and overall solutions of instruments and in vitro diagnostic reagents in the field of genetic testing and molecular diagnostics. With its own sustainable development and potential values, Tianlong has received investments from SK Group, the 57th largest company in the Fortune Global 500 list, and Kehua Bio-Engineering, a listed company in China, in 2012 and 2018.



As a high-tech enterprise in China, Tianlong Technology is responsible for many major scientific research and industrialization projects such as the National Key Research and Development Program, the National Special Project for the Development of Major Scientific Instruments and Equipment, and the National Science and Technology Support Program. ISO9001-certified and 13485-standard, Tianlong now has hundreds of products such as nucleic acid extractor, automated nucleic acid workstation, gene amplification instruments, real-time PCR instruments, ATP fluorescence detector and supporting test reagents. over 50 products have been approved by NMPA with medical device registration certificates, and more than 20 products have been approved by EU (CE) and KFDA (South Korea).



Tianlong products are widely applied in the fields of medical diagnosis, food safety, epidemic prevention and control, customs and quarantine, forensics, scientific research, etc., and have contributed to the prevention and control of various major epidemics such as avian flu, Ebola, MERS, African swine fever and neonatal pneumonia. At present, Tianlong is serving more than 2,000 customers in more than 40 countries and regions including, Korea, the United States, France, Germany, Denmark, the United Arab Emirates, Pakistan, and so on.



At the end of 2019, after the outbreak of the COVID-19 epidemic, Tianlong quickly launched SARS-CoV-2 rapid nucleic acid detection solution, successively detected the first positive samples in many provinces in China, and made a great contribution to the epidemic prevention and control globally. Tianlong successively received letters of thanks from the State Council of China, the National Center for Disease Control of China, and the Slovakian government. Tianlong was then reported by CCTV News, Xinhua News Agency, People's Daily and other authoritative media.



In the face of future opportunities and challenges, we will continue to create first-class molecular diagnostic products and work hard for human health in a more open way of cooperation with all walks of life.